Anti-cancer agents for breast cancer treatment during pregnancy

Authors

  • Paul Berveiller MSc, MD,

    Corresponding author
    1. Faculty of Pharmaceutical and Biological Sciences, PremUp Foundation, Paris Descartes University, Paris, France
    2. French Group CALG (Cancers Associés à La Grossesse), Paris, France
    • Pharmaceutical and Biological Sciences Faculty, PremUp Foundation, 4 Avenue de l'Observatoire, F75006 Paris, France. Fax: +00-33-179-724-388.===

    Search for more papers by this author
  • Nicolas Veyrie MSc, MD,

    1. Department of Digestive Surgery, Cochin Teaching Hospital, Paris Descartes University, AP-HP, Paris, France
    Search for more papers by this author
  • Roman Rouzier MD, PhD,

    1. French Group CALG (Cancers Associés à La Grossesse), Paris, France
    2. Department of Obstetrics and Gynecology, Tenon Teaching Hospital, Pierre et Marie Curie University, AP-HP, Paris, France
    Search for more papers by this author
  • Bruno Carbonne MSc, MD,

    1. Department of Obstetrics and Gynecology, Saint-Antoine Teaching Hospital, Pierre et Marie Curie University, AP-HP, Paris, France
    Search for more papers by this author
  • Olivier Mir MSc, MD, MPH

    1. French Group CALG (Cancers Associés à La Grossesse), Paris, France
    2. Department of Medical Oncology, Cochin Teaching Hospital, Paris Descartes University, AP-HP, Paris, France
    Search for more papers by this author

No abstract is available for this article.

Ancillary